Evidence map›Paper›PMID 22103612›Full record

ReviewBiomarkers in medicine2011

Development of biomarkers to optimize pediatric patient management: what makes children different?

Jennifer Goldman, Mara L Becker, Bridgette Jones, Mark Clements, J Steven Leeder

Abstract readReview
In one paragraph

Review in Biomarkers in medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Utility of Novel Kidney Injury Biomarkers in Early Detection of CSA-AKI.International journal of molecular sciences · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The PedBE clock accurately estimates DNA methylation age in pediatric buccal cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jennifer GoldmanDivision of Clinical Pharmacology & Medical Toxicology, Children's Mercy Hospitals & Clinics & University of Missouri-Kansas City, Kansas City, MO, USA.
Mara L Becker
Bridgette Jones
Mark Clements
J Steven Leeder

Funding

Childrens Mercy Hospital Fellowship Program in Pediatric PharmacologyT32HD069038 · NICHD · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Laura B Ramsey, Jonathan Wagner · 2011 to 2026
$3.1M
Exogenous and Endogenous Biomarkers of CYP2D6 Variability in PediatricsR01HD058556 · NICHD · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI LEEDER, JAMES STEVEN, LIN, YVONNE SARAH · 2010 to 2014
$2.7M
Characterization of the Role of Histamine in Children with AsthmaK23HL105783 · NHLBI · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI JONES, BRIDGETTE L. · 2011 to 2015
$641k
CYTOCHROME P450 ACTIVITY IN THE FIRST YEAR OF LIFER03HD036783 · NICHD · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI LEEDER, JAMES STEVEN · 1998 to 1999
–
NHLBI NIH HHS K23 HL105783NICHD NIH HHS R01 HD058556NICHD NIH HHS R03 HD36783NICHD NIH HHS T32 HD069038
6 · The paper itself

Abstract

Despite the frequent utilization of biomarkers in medical practice, there is a relative paucity of information regarding validated pediatric biomarkers. Frequently, biomarkers found to be efficacious in adults are extrapolated to the pediatric clinical setting without considering that the pathogenesis of many diseases is distinctly different in children, and ontogeny directly influences disease evolution and therapeutic response in children. New and innovative approaches are necessary to provide reliable, validated biomarkers that can be used to improve and advance pediatric medical care.

Indexed as

Arthritis, JuvenileBiomarkersChildFolic AcidGenotypeHumansMethotrexatePediatricsPharmacogeneticsReference ValuesBiomarkersFolic AcidMethotrexate

Identifiers

PMID22103612
PMCPMC3321646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.